Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

<p><strong>Background</strong> Quinquennial overviews (1985–2000) of the randomised trials in early breast cancer have assessed the 5 year and 10-year effects of various systemic adjuvant therapies on breast cancer recurrence and survival. Here, we report the 10-year and 15-year ef...

书目详细资料
主要作者:	Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
格式:	Journal article
语言:	English
出版:	Elsevier 2005

相似书籍

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
由: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
出版: (2005)

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials
由: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
出版: (2011)

Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials
由: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
出版: (2008)

Polychemotherapy for early breast cancer: an overview of the randomised trials
由: Early Breast Cancer Trialists' Collaborative Group
出版: (1998)

Tamoxifen for early breast cancer: an overview of the randomised trials
由: Early Breast Cancer Trialists' Collaborative Group
出版: (1998)

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
由: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
出版: (2011)

Ovarian ablation in early breast cancer: overview of the randomised trials
由: Early Breast Cancer Trialists' Collaborative Group
出版: (1996)

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast
由: Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
出版: (2010)

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
由: Early Breast Cancer Trialists’ Collaborative group (EBCTCG)
出版: (2021)

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
由: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
出版: (2014)

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
由: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
出版: (2011)

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: patient level meta-analysis of 7,030 women in four randomised trials
由: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
出版: (2022)

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
由: Early Breast Cancer Trialists’ Collaborative Group
出版: (2017)

Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials
由: Early Breast Cancer Trialists' Collaborative Group
出版: (1995)

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer
由: Early Breast Cancer Trialists' Collaborative Group
出版: (1988)

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women
由: Early Breast Cancer Trialist's Collaborative Group
出版: (1992)

20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years
由: Pan, H, et al.
出版: (2017)

Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer (2024 edition)
由: Committee of Breast Cancer Society, China Anti-Cancer Association
出版: (2024-03-01)

Overview of the Randomised Trials of Radiotherapy in Early Breast Cancer.
由: Darby, S, et al.
出版: (2009)

Guidelines for breast cancer diagnosis and treatment by China Anti-cancer Association (2024 edition)
由: The Society of Breast Cancer China Anti-Cancer Association, Breast Oncology Group of the Oncology Branch of the Chinese Medical Association
出版: (2023-12-01)

SPECIFIC FEATURE OF HORMONAL PROFILE IN PATIENTS WITH PRIMARY AND RECURRENT BREAST CANCER AND THEIR ROLE IN THE EFFICIENCY OF CHEMOTHERAPY
由: M. B. Kozlova, et al.
出版: (2014-09-01)

Locoregional recurrence and survival of breast−conserving surgery compared to mastectomy following neoadjuvant chemotherapy in operable breast cancer
由: Fa-you Lv, et al.
出版: (2024-03-01)

Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials.
由: CLL Trialists’ Collaborative Group
出版: (2012)

The benefits and harms of breast cancer screening: an independent review.
由: Independent UK Panel on Breast Cancer Screening
出版: (2012)

Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.
由: Stem Cell Trialists' Collaborative Group
出版: (2005)

Details of a prospective protocol for a collaborative meta-analysis of individual participant data from all randomized trials of intravenous rt-PA vs. control: statistical analysis plan for the Stroke Thrombolysis Trialists' Collaborative meta-analysis.
由: Stroke Thrombolysis Trialists' Collaborative Group
出版: (2013)

Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials
由: CLL Trialists’ Collaborative Group (CLLTCG)
出版: (2012-03-01)

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer.
由: Cancer, C
出版: (1996)

Impact of adjuvant chemotherapy on the survival of patients with breast cancer diagnosed by screening
由: Irene Zarcos‐Pedrinaci, et al.
出版: (2019-11-01)

Recurrence-Free Survival after Postoperative Hormone Therapy for Catamenial Pneumothorax
由: Ji Hoon Kim, et al.
出版: (2024-09-01)

Febrile neutropenia recurrence after chemotherapy in patients with breast cancer
由: Simone Yuriko Kameo, Glebson Moura Silva, Namie Okino Sawada, Mary Elizabeth de Santana
出版: (2020-10-01)

Adjuvant trastuzumab chemotherapy in early breast cancer: meta-analysis of randomised trials and cost-effectiveness analysis
由: Tan Nhut Doan, et al.
出版: (2019-05-01)

Strain ultrasonic elastography imaging features of locally advanced breast cancer: association with response to neoadjuvant chemotherapy and recurrence-free survival
由: Caifeng Wan, et al.
出版: (2023-12-01)

The impact of extensive intraductal component (EIC) on the genomic risk of recurrence in early hormone receptor positive breast cancer
由: Yael Bar, et al.
出版: (2024-10-01)

NOTIFICATION: Development of a Novel Approach for Breast Cancer Prediction and Early Detection Using Minimally Invasive Procedures and Molecular Analysis: How Cytomorphology Became a Breast Cancer Risk Predictor
由: The Breast Journal
出版: (2025-01-01)

Impact of various options of neoadjuvant chemotherapy on the hormonal status of patients with breast cancer
由: Yu. S. Sidorenko, et al.
出版: (2014-08-01)

Chemotherapy in older patients with early breast cancer
由: Marcus Schmidt, et al.
出版: (2024-12-01)

Relationship between weight change during chemotherapy and recurrence in breast cancer
由: Kwangwook Seo, et al.
出版: (2013-12-01)

GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer
由: Volker Möbus, et al.
出版: (2024-07-01)

“Moderate” adjuvant chemotherapy-induced leukopenia is beneficial for survival of patients with early breast cancer: a retrospective study
由: Li Wang, et al.
出版: (2023-12-01)